AAV Gene Therapy: Monitoring Manufacturing Adeno-associated viruses (AAV) have revolutionised gene therapies as safe and effective gene shuttles. The growing demand for AAV vectors now requires an industrialised process throughout pre-clinical … more ➔
Increase viral RNA extraction throughput w...During the global COVID-19 outbreak, BioEcho developed a rapid extraction protocol that reduced the isolation of SARS-CoV-2-RNA to just a few minutes. Currently, BioEcho offers a CE-marked viral RNA/DNA … more ➔
Lasers for Biomedical Optics and Imaging A... No matter whether you’re an end user or an OEM in biophotonics, biomedical optics, and imaging, Coherent has the laser that perfectly matches your needs and your budget. more ➔
Biopharma partnerships a key to success Innovators at Rentschler Biopharma are continuously developing new processes for biopharmaceutical production to tackle life-threatening diseases. Two of them, Dr Birgit Ehrenberg, Process Manager, … more ➔
European Biotechnology Guide 2021The 11th edition of the European Biotechnology Science & Industry Guide once more offers an interesting cross-section of the European biotech scene. more ➔
IZB Start-up: Exosome DiagnosticsExosome Diagnostics develops biofluid-based molecular diagnostic tests for use in personalized medicine and collaborates with pharmaceutical companies to develop companion diagnostics (CDx). more ➔
Market trends and the biopharma evolutionWith many complex factors affecting a therapeutic candidates chances of approval, partnering with a qualified service provider can be the most effective way to produce material for clinical trials. … more ➔
A very “cool” topic in the par...The current debates regarding vaccine production and logistics have also made it clear even to the layman: Pharmaceutical production depends on cold. Temperatures below -80?°C are just as common as … more ➔
Novel RNA extraction method speeds up COVI... Although innovative biotechnologies are developed continuously, the method of nucleic acid extraction stayed unchanged for several decades. The classical bind-wash-elute approach seemed sufficient, … more ➔
Origenis founds biotech company Neuron23 Together with star investor Kleiner Perkins, Origenis GmbH, a privately held German biopharmaceutical company, successfully establishes its new business model for the clinical development of its neuroprotective … more ➔
